Earl Martin Douglas, SVP, General Counsel: Allogene Therapeutics ALLO Sell · Filed 02/04

Trade details

Type: Insider sale
Amount: $40,304
Shares · price: 22,900 sh · $1.76 a share
Held after: 564,948 sh
Stock: Allogene Therapeutics ALLO
Person: Earl Martin DouglasSVP, General Counsel
Trade date: 26/02/02
Filed: 26/02/04
Days to filing: 2 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 01/03~03/04

Earl Martin Douglas's recent trades

Earl Martin DouglasSVP, General Counsel
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$63K
29,697 sh
$63K
Filed 08/21
Traded 08/21
Earl Martin DouglasSVP, General Counsel
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$40.2K
22,900 sh
$40.2K
Filed 02/02
Traded 02/02
Earl Martin DouglasSVP, General Counsel
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$11K
6,404 sh
$11K
Filed 25/02/05
Traded 25/02/03
Earl Martin DouglasOfficer
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$11K
6,404 sh
$11K
Filed 25/02/03
Traded 25/02/03